Kerschbaumer, J., & Seiz-Rosenhagen, M. (2015). Dual anti-angiogenic chemotherapy with temozolomide and celecoxib in selected patients with malignant glioma not eligible for standard treatment. Anticancer research, 35(9), . https://doi.org/undefined
Chicago-Zitierstil (17. Ausg.)Kerschbaumer, Johannes, und Marcel Seiz-Rosenhagen. "Dual Anti-angiogenic Chemotherapy with Temozolomide and Celecoxib in Selected Patients with Malignant Glioma Not Eligible for Standard Treatment." Anticancer Research 35, no. 9 (2015). https://doi.org/undefined.
MLA-Zitierstil (9. Ausg.)Kerschbaumer, Johannes, und Marcel Seiz-Rosenhagen. "Dual Anti-angiogenic Chemotherapy with Temozolomide and Celecoxib in Selected Patients with Malignant Glioma Not Eligible for Standard Treatment." Anticancer Research, vol. 35, no. 9, 2015, https://doi.org/undefined.